Scinai Immunotherapeutics Ltd. (SCNI)
NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 2.55M |
| Enterprise Value | 16.00M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 1.59 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -1.55 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 2.45 |
| 52-Week Change 3 | -76.34% |
| S&P500 52-Week Change 3 | 25.38% |
| 52 Week High 3 | 2.2700 |
| 52 Week Low 3 | 0.4310 |
| 50-Day Moving Average 3 | 0.4848 |
| 200-Day Moving Average 3 | 0.7402 |
Share Statistics
| Avg Vol (3 month) 3 | 26.89k |
| Avg Vol (10 day) 3 | 11.3k |
| Shares Outstanding 5 | 5.81M |
| Implied Shares Outstanding 6 | 4.73M |
| Float 8 | 1.02B |
| % Held by Insiders 1 | 24.21% |
| % Held by Institutions 1 | 10.63% |
| Shares Short (Apr 15, 2024) 4 | 22.54k |
| Short Ratio (Apr 15, 2024) 4 | 0.84 |
| Short % of Float (Apr 15, 2024) 4 | 0.57% |
| Short % of Shares Outstanding (Apr 15, 2024) 4 | 0.52% |
| Shares Short (prior month Mar 15, 2024) 4 | 12.74k |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 1:10 |
| Last Split Date 3 | Nov 25, 2022 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2022 |
| Most Recent Quarter (mrq) | Sept 30, 2023 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | 0.00% |
Management Effectiveness
| Return on Assets (ttm) | -35.71% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -10.29M |
| Net Income Avi to Common (ttm) | -9.29M |
| Diluted EPS (ttm) | -4.4000 |
| Quarterly Earnings Growth (yoy) | 216.30% |
Balance Sheet
| Total Cash (mrq) | 6.36M |
| Total Cash Per Share (mrq) | 0 |
| Total Debt (mrq) | 19.81M |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 4.36 |
| Book Value Per Share (mrq) | -0.62 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -8.75M |
| Levered Free Cash Flow (ttm) | -8.7M |
© 2024 Yahoo. All rights reserved.